JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valentino, R. J.
Right arrow Articles by Wehby, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valentino, R. J.
Right arrow Articles by Wehby, R. G.

Antidepressant actions on brain noradrenergic neurons

RJ Valentino, AL Curtis, DG Parris and RG Wehby

Department of Pharmacology, George Washington University Medical Center, Washington, D.C.

Corticotropin-releasing factor (CRF), the hormone responsible for adrenocorticotropin release during stress, is thought to be hypersecreted in depression. Because recent studies suggest that CRF may serve as a neurotransmitter in the major noradrenergic nucleus, locus coeruleus (LC), it was hypothesized that antidepressants interfere with the putative neurotransmitter role of CRF in the LC by either: 1) decreasing release of CRF; 2) pharmacologically antagonizing CRF; or 3) functionally antagonizing CRF by producing effects on LC cells that oppose these of CRF. In order to test this hypothesis, the effects of acute and chronic administration of two antidepressants, a norepinephrine re-uptake inhibitor (desmethylimipramine, DMI) and a serotonin re-uptake inhibitor (sertraline, SER), on LC spontaneous discharge, LC sensory evoked discharge, LC activation by a stressor and LC activation by CRF, were compared in halothane-anesthetized rats. Acute i.v. administration of DMI decreased both LC spontaneous discharge and discharge evoked by repeated sciatic nerve stimulation. In contrast, acute i.v. SER administration decreased only evoked LC discharge rate. Chronic DMI administration (10.0 mg/kg/day, i.p., 21 days) resulted in tolerance to its effects on spontaneous and sensory- evoked LC discharge. However, chronic DMI administration attenuated LC activation by hemodynamic stress, which is thought to require CRF release. LC activation by intracerebroventricular CRF was not altered in the chronic DMI rats. In contrast to DMI, chronic SER (10 mg/kg/day, i.p., 21 days) did not alter LC activation by either stress of CRF. However, the response of LC cells to repeated sciatic nerve stimulation was somewhat enhanced in chronic SER rats. This is an effect that is opposite that produced by CRF.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 253, Issue 2, pp. 833-840, 05/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
E. Berrocoso and J. A. Mico
In Vivo Effect of Venlafaxine on Locus Coeruleus Neurons: Role of Opioid, {alpha}2-Adrenergic, and 5-Hydroxytryptamine1A Receptors
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
L. Dazzi, V. Vignone, E. Seu, S. Ladu, G. Vacca, and G. Biggio
Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142
J Psychopharmacol, March 1, 2002; 16(2): 125 - 131.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
D. N. Thomas, D. J. Nutt, and R. B. Holman
Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex
J Psychopharmacol, January 1, 1998; 12(4): 366 - 370.
[Abstract] [PDF]


Home page
NeuroscientistHome page
S. Heit, M. J. Owens, P. Plotsky, and C. B. Nemeroff
{blacksquare} REVIEW : Corticotropin-releasing Factor, Stress, and Depression
Neuroscientist, May 1, 1997; 3(3): 186 - 194.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
R. C. Veith, N. Lewis, O. A. Linares, R. F. Barnes, M. A. Raskind, E. C. Villacres, M. M. Murburg, E. A. Ashleigh, S. Castillo, E. R. Peskind, et al.
Sympathetic Nervous System Activity in Major Depression: Basal and Desipramine-Induced Alterations in Plasma Norepinephrine Kinetics
Arch Gen Psychiatry, May 1, 1994; 51(5): 411 - 422.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.